8 research outputs found

    Body composition and cardiometabolic risk markers in children of women who took part in a randomized controlled trial of a pre-conceptional nutritional intervention in Mumbai, India

    No full text
    BackgroundMaternal nutrition influences fetal development and may permanently alter (‘program’) offspring body composition and metabolism, thereby influencing later risk of diabetes and cardiovascular (cardiometabolic) disease. The prevalence of cardiometabolic disease is rising rapidly in India.ObjectivesTo test the hypothesis that supplementing low-income Indian women with micronutrient-rich foods pre-conceptionally and during pregnancy has a beneficial impact on the children's body composition and cardiometabolic risk marker profiles.DesignFollow-up of 1,255 children aged 5–10 years whose mothers took part in the Mumbai Maternal Nutrition Project (Project “SARAS”; ISRCTN62811278). Mothers were randomized to receive a daily micronutrient-rich snack or a control snack of lower micronutrient content, both made from local foods, in addition to normal diet, from before pregnancy until delivery. Children's body composition was assessed using anthropometry and dual X-ray absorptiometry (DXA). Their blood pressure, plasma glucose, insulin and lipid concentrations were measured. Outcomes were compared between allocation groups with and without adjustment for confounding factors.ResultsOverall, 15% of children were stunted, 34% were wasted and 3% were overweight. In the intention to treat analysis, there were no differences in body composition or risk markers between children in the intervention and control groups. Among children whose mothers started supplementation ≄ 3 months before conception (the ‘per protocol’ sample) the intervention increased adiposity among girls, but not boys. BMI in girls was increased relative to controls by 2% (95%CI 1, 4; P = 0.01); fat mass index by 10% (95%CI 3, 18; P = 0.004); and fat% by 7% (95%CI 1, 13; P = 0.01) unadjusted, with similar results in adjusted models.ConclusionsOverall, supplementing women with micronutrient-rich foods from before pregnancy until delivery did not alter the body composition or cardiometabolic risk markers in the children. Sub-group analyses showed that, if started at least 3 months before conception, supplementation may increase adiposity among female children

    Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future

    Get PDF
    The congenital heart care community faces a myriad of public health issues that act as barriers toward optimum patient outcomes. In this article, we attempt to define advocacy and policy initiatives meant to spotlight and potentially address these challenges. Issues are organized into the following 3 key facets of our community: patient population, health care delivery, and workforce. We discuss the social determinants of health and health care disparities that affect patients in the community that require the attention of policy makers. Furthermore, we highlight the many needs of the growing adults with congenital heart disease and those with comorbidities, highlighting concerns regarding the inequities in access to cardiac care and the need for multidisciplinary care. We also recognize the problems of transparency in outcomes reporting and the promising application of telehealth. Finally, we highlight the training of providers, measures of productivity, diversity in the workforce, and the importance of patient– family centered organizations in advocating for patients. Although all of these issues remain relevant to many subspecialties in medicine, this article attempts to illustrate the unique needs of this population and highlight ways in which to work together to address important opportunities for change in the cardiac care community and beyond. This article provides a framework for policy and advocacy efforts for the next decade

    mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study

    No full text
    In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions

    Challenges With Left Ventricular Functional Parameters: The Pediatric Heart Network Normal Echocardiogram Database

    No full text
    corecore